世界のOTC胃腸製品市場予測2023-2029:H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)

【英語タイトル】OTC Gastrointestinal Products Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23JU5863)・商品コード:MMG23JU5863
・発行会社(調査会社):Market Monitor Global
・発行日:2023年6月
・ページ数:77
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のOTC胃腸製品市場規模と予測を収録しています。・世界のOTC胃腸製品市場:売上、2018年-2023年、2024年-2029年
・世界のOTC胃腸製品市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のOTC胃腸製品市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「H2受容体拮抗薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

OTC胃腸製品のグローバル主要企業は、GlaxoSmithKline、 Merck、 Novartis、 Bayer、 Pfizer、 Bristol-Myers Squibbなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、OTC胃腸製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のOTC胃腸製品市場:タイプ別、2018年-2023年、2024年-2029年
世界のOTC胃腸製品市場:タイプ別市場シェア、2022年
・H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)

世界のOTC胃腸製品市場:用途別、2018年-2023年、2024年-2029年
世界のOTC胃腸製品市場:用途別市場シェア、2022年
・病院薬局、ドラッグストア、小売店、Eコマース

世界のOTC胃腸製品市場:地域・国別、2018年-2023年、2024年-2029年
世界のOTC胃腸製品市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるOTC胃腸製品のグローバル売上、2018年-2023年
・主要企業におけるOTC胃腸製品のグローバル売上シェア、2022年
・主要企業におけるOTC胃腸製品のグローバル販売量、2018年-2023年
・主要企業におけるOTC胃腸製品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline、 Merck、 Novartis、 Bayer、 Pfizer、 Bristol-Myers Squibb

*************************************************************

・調査・分析レポートの概要
OTC胃腸製品市場の定義
市場セグメント
世界のOTC胃腸製品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のOTC胃腸製品市場規模
世界のOTC胃腸製品市場規模:2022年 VS 2029年
世界のOTC胃腸製品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのOTC胃腸製品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のOTC胃腸製品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)
OTC胃腸製品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院薬局、ドラッグストア、小売店、Eコマース
OTC胃腸製品の用途別グローバル売上・予測

・地域別市場分析
地域別OTC胃腸製品市場規模 2022年と2029年
地域別OTC胃腸製品売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
GlaxoSmithKline、 Merck、 Novartis、 Bayer、 Pfizer、 Bristol-Myers Squibb
...

OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.
This report aims to provide a comprehensive presentation of the global market for OTC Gastrointestinal Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Gastrointestinal Products. This report contains market size and forecasts of OTC Gastrointestinal Products in global, including the following market information:
Global OTC Gastrointestinal Products Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global OTC Gastrointestinal Products Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five OTC Gastrointestinal Products companies in 2022 (%)
The global OTC Gastrointestinal Products market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
H2 Receptor Antagonists Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of OTC Gastrointestinal Products include GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the OTC Gastrointestinal Products manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OTC Gastrointestinal Products Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global OTC Gastrointestinal Products Market Segment Percentages, by Type, 2022 (%)
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
Global OTC Gastrointestinal Products Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global OTC Gastrointestinal Products Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Global OTC Gastrointestinal Products Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global OTC Gastrointestinal Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OTC Gastrointestinal Products revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies OTC Gastrointestinal Products revenues share in global market, 2022 (%)
Key companies OTC Gastrointestinal Products sales in global market, 2018-2023 (Estimated), (K Units)
Key companies OTC Gastrointestinal Products sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Novartis
Bayer
Pfizer
Bristol-Myers Squibb
Outline of Major Chapters:
Chapter 1: Introduces the definition of OTC Gastrointestinal Products, market overview.
Chapter 2: Global OTC Gastrointestinal Products market size in revenue and volume.
Chapter 3: Detailed analysis of OTC Gastrointestinal Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OTC Gastrointestinal Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global OTC Gastrointestinal Products capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 OTC Gastrointestinal Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global OTC Gastrointestinal Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global OTC Gastrointestinal Products Overall Market Size
2.1 Global OTC Gastrointestinal Products Market Size: 2022 VS 2029
2.2 Global OTC Gastrointestinal Products Revenue, Prospects & Forecasts: 2018-2029
2.3 Global OTC Gastrointestinal Products Sales: 2018-2029
3 Company Landscape
3.1 Top OTC Gastrointestinal Products Players in Global Market
3.2 Top Global OTC Gastrointestinal Products Companies Ranked by Revenue
3.3 Global OTC Gastrointestinal Products Revenue by Companies
3.4 Global OTC Gastrointestinal Products Sales by Companies
3.5 Global OTC Gastrointestinal Products Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 OTC Gastrointestinal Products Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers OTC Gastrointestinal Products Product Type
3.8 Tier 1, Tier 2 and Tier 3 OTC Gastrointestinal Products Players in Global Market
3.8.1 List of Global Tier 1 OTC Gastrointestinal Products Companies
3.8.2 List of Global Tier 2 and Tier 3 OTC Gastrointestinal Products Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global OTC Gastrointestinal Products Market Size Markets, 2022 & 2029
4.1.2 H2 Receptor Antagonists
4.1.3 Proton Pump Inhibitors (PPIs)
4.2 By Type – Global OTC Gastrointestinal Products Revenue & Forecasts
4.2.1 By Type – Global OTC Gastrointestinal Products Revenue, 2018-2023
4.2.2 By Type – Global OTC Gastrointestinal Products Revenue, 2024-2029
4.2.3 By Type – Global OTC Gastrointestinal Products Revenue Market Share, 2018-2029
4.3 By Type – Global OTC Gastrointestinal Products Sales & Forecasts
4.3.1 By Type – Global OTC Gastrointestinal Products Sales, 2018-2023
4.3.2 By Type – Global OTC Gastrointestinal Products Sales, 2024-2029
4.3.3 By Type – Global OTC Gastrointestinal Products Sales Market Share, 2018-2029
4.4 By Type – Global OTC Gastrointestinal Products Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global OTC Gastrointestinal Products Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Drug Stores
5.1.4 Retail Stores
5.1.5 E-Commerce
5.2 By Application – Global OTC Gastrointestinal Products Revenue & Forecasts
5.2.1 By Application – Global OTC Gastrointestinal Products Revenue, 2018-2023
5.2.2 By Application – Global OTC Gastrointestinal Products Revenue, 2024-2029
5.2.3 By Application – Global OTC Gastrointestinal Products Revenue Market Share, 2018-2029
5.3 By Application – Global OTC Gastrointestinal Products Sales & Forecasts
5.3.1 By Application – Global OTC Gastrointestinal Products Sales, 2018-2023
5.3.2 By Application – Global OTC Gastrointestinal Products Sales, 2024-2029
5.3.3 By Application – Global OTC Gastrointestinal Products Sales Market Share, 2018-2029
5.4 By Application – Global OTC Gastrointestinal Products Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global OTC Gastrointestinal Products Market Size, 2022 & 2029
6.2 By Region – Global OTC Gastrointestinal Products Revenue & Forecasts
6.2.1 By Region – Global OTC Gastrointestinal Products Revenue, 2018-2023
6.2.2 By Region – Global OTC Gastrointestinal Products Revenue, 2024-2029
6.2.3 By Region – Global OTC Gastrointestinal Products Revenue Market Share, 2018-2029
6.3 By Region – Global OTC Gastrointestinal Products Sales & Forecasts
6.3.1 By Region – Global OTC Gastrointestinal Products Sales, 2018-2023
6.3.2 By Region – Global OTC Gastrointestinal Products Sales, 2024-2029
6.3.3 By Region – Global OTC Gastrointestinal Products Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America OTC Gastrointestinal Products Revenue, 2018-2029
6.4.2 By Country – North America OTC Gastrointestinal Products Sales, 2018-2029
6.4.3 US OTC Gastrointestinal Products Market Size, 2018-2029
6.4.4 Canada OTC Gastrointestinal Products Market Size, 2018-2029
6.4.5 Mexico OTC Gastrointestinal Products Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe OTC Gastrointestinal Products Revenue, 2018-2029
6.5.2 By Country – Europe OTC Gastrointestinal Products Sales, 2018-2029
6.5.3 Germany OTC Gastrointestinal Products Market Size, 2018-2029
6.5.4 France OTC Gastrointestinal Products Market Size, 2018-2029
6.5.5 U.K. OTC Gastrointestinal Products Market Size, 2018-2029
6.5.6 Italy OTC Gastrointestinal Products Market Size, 2018-2029
6.5.7 Russia OTC Gastrointestinal Products Market Size, 2018-2029
6.5.8 Nordic Countries OTC Gastrointestinal Products Market Size, 2018-2029
6.5.9 Benelux OTC Gastrointestinal Products Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia OTC Gastrointestinal Products Revenue, 2018-2029
6.6.2 By Region – Asia OTC Gastrointestinal Products Sales, 2018-2029
6.6.3 China OTC Gastrointestinal Products Market Size, 2018-2029
6.6.4 Japan OTC Gastrointestinal Products Market Size, 2018-2029
6.6.5 South Korea OTC Gastrointestinal Products Market Size, 2018-2029
6.6.6 Southeast Asia OTC Gastrointestinal Products Market Size, 2018-2029
6.6.7 India OTC Gastrointestinal Products Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America OTC Gastrointestinal Products Revenue, 2018-2029
6.7.2 By Country – South America OTC Gastrointestinal Products Sales, 2018-2029
6.7.3 Brazil OTC Gastrointestinal Products Market Size, 2018-2029
6.7.4 Argentina OTC Gastrointestinal Products Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa OTC Gastrointestinal Products Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa OTC Gastrointestinal Products Sales, 2018-2029
6.8.3 Turkey OTC Gastrointestinal Products Market Size, 2018-2029
6.8.4 Israel OTC Gastrointestinal Products Market Size, 2018-2029
6.8.5 Saudi Arabia OTC Gastrointestinal Products Market Size, 2018-2029
6.8.6 UAE OTC Gastrointestinal Products Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline OTC Gastrointestinal Products Major Product Offerings
7.1.4 GlaxoSmithKline OTC Gastrointestinal Products Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck OTC Gastrointestinal Products Major Product Offerings
7.2.4 Merck OTC Gastrointestinal Products Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis OTC Gastrointestinal Products Major Product Offerings
7.3.4 Novartis OTC Gastrointestinal Products Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer OTC Gastrointestinal Products Major Product Offerings
7.4.4 Bayer OTC Gastrointestinal Products Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer OTC Gastrointestinal Products Major Product Offerings
7.5.4 Pfizer OTC Gastrointestinal Products Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Major Product Offerings
7.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Sales and Revenue in Global (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
8 Global OTC Gastrointestinal Products Production Capacity, Analysis
8.1 Global OTC Gastrointestinal Products Production Capacity, 2018-2029
8.2 OTC Gastrointestinal Products Production Capacity of Key Manufacturers in Global Market
8.3 Global OTC Gastrointestinal Products Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 OTC Gastrointestinal Products Supply Chain Analysis
10.1 OTC Gastrointestinal Products Industry Value Chain
10.2 OTC Gastrointestinal Products Upstream Market
10.3 OTC Gastrointestinal Products Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 OTC Gastrointestinal Products Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界のOTC胃腸製品市場予測2023-2029:H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)] (コード:MMG23JU5863)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のOTC胃腸製品市場予測2023-2029:H2受容体拮抗薬、プロトンポンプ阻害薬(PPI)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆